Advanced search
Publication Cover
Modern Rheumatology Volume 28, 2018 - Issue 5
Journal homepage
242
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still’s disease: A multicenter retrospective study

Yohei KirinoDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Kanagawa, Japan; ORCID Iconhttp://orcid.org/0000-0002-9488-661XView further author information
ORCID Icon,
Yasushi KawaguchiInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information
,
Yoshifumi TadaDivision of Rheumatology, Department of Internal Medicine, Saga University, Saga, Japan; View further author information
,
Hiroshi TsukamotoDepartment of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan; View further author information
,
Toshiyuki OtaDepartment of Rheumatology, Iizuka Hospital, Fukuoka, Japan; View further author information
,
Masahiro IwamotoDivision of Rheumatology/Clinical Immunology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan; View further author information
,
Hiroki TakahashiDepartment of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, Hokkaido, Japan; View further author information
,
Kohei NagasawaRheumatic Disease Center, Sawara Hospital, Fukuoka, Japan; View further author information
,
Shuji TakeiFaculty of Medicine, Kagoshima University, School of Health Sciences, Kagoshima, Japan; View further author information
,
Takahiko HoriuchiDepartment of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan; View further author information
,
Hisae IchidaInstitute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan; View further author information
,
Seiji MinotaDivision of Rheumatology/Clinical Immunology, Department of Internal Medicine, Jichi Medical University, Tochigi, Japan; View further author information
,
Atsuhisa UedaDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, Kanagawa, Japan; View further author information
,
Akihide OhtaFaculty of Medicine (presently Kohokai Group Medical Corporation), Saga University, Saga, Japan; View further author information
&
Yoshiaki IshigatsuboYokohama City University School of Medicine, Kanagawa, JapanCorrespondence[email protected]
View further author information
 show all
Pages 858-864 | Received 28 Aug 2017, Accepted 18 Dec 2017, Published online: 11 Jan 2018

References

  • Bywaters EG. Still’s disease in the adult. Ann Rheum Dis. 1971;30(2):121–33.
  • Asanuma YF, Mimura T, Tsuboi H, Noma H, Miyoshi F, Yamamoto K, et al Nationwide epidemiological survey of 169 patients with adult Still’s disease in Japan. Mod Rheumatol. 2015;25(3):393–400.
  • Kadavath S, Efthimiou P. Adult-onset Still’s disease-pathogenesis, clinical manifestations, and new treatment options. Ann Med. 2015;47(1):6–14.
  • Jamilloux Y, Gerfaud-Valentin M, Martinon F, Belot A, Henry T, Seve P. Pathogenesis of adult-onset Still’s disease: new insights from the juvenile counterpart. Immunol Res. 2015;61(1–2):53–62.
  • Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19(3):424–30.
  • Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81(3):194–200.
  • Cush JJ, Medsger TA Jr., Christy WC, Herbert DC, Cooperstein LA. Adult-onset Still’s disease. Clinical course and outcome. Arthritis Rheum. 1987;30(2):186–94.
  • Ota T, Higashi S, Suzuki H, Eto S. Increased serum ferritin levels in adult Still’s disease. Lancet. 1987;1(8532):562–3.
  • Mitrovic S, Fautrel B. New markers for adult-onset Still’s disease. Joint Bone Spine. 2017 [May 18]. doi: 10.1016/j.jbspin.2017.05.011
  • Kirino Y, Takeno M, Iwasaki M, Ueda A, Ohno S, Shirai A, et al. Increased serum HO-1 in hemophagocytic syndrome and adult-onset Still's disease: use in the differential diagnosis of hyperferritinemia. Arthritis Res Ther. 2005;7(3):R616–24.
  • Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis Rheumatol. 2016;68(3):566–76.
  • Pouchot J, Sampalis JS, Beaudet F, Carette S, Decary F, Salusinsky-Sternbach M, et al. Adult Still’s disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore). 1991; 70(2):118–36.
  • Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S, et al. Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol. 2001;28(2):322–9.
  • Kawashima M, Yamamura M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still’s disease. Arthritis Rheum. 2001;44(3):550–60.
  • Jung SY, Park YB, Ha YJ, Lee KH, Lee SK. Serum calprotectin as a marker for disease activity and severity in adult-onset Still’s disease. J Rheumatol. 2010;37(5):1029–34.
  • Higashi S, Ota T, Eto S. Biochemical analysis of ferritin subunits in sera from adult Still’s disease patients. Rheumatol Int. 1995;15(2):45–50.
  • Bae CB, Jung JY, Kim HA, Suh CH. Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore). 2015;94(4):e451.
  • Ruscitti P, Cipriani P, Masedu F, Iacono D, Ciccia F, Liakouli V, et al. Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers. BMC Med. 2016;14(1):194.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.